LONDON – "I believe the world is on the verge of an effective Ebola vaccine." So said Marie-Paule Kieny, assistant director general of the World Health Organization (WHO) announcing positive results for the phase III trial of the Merck and Co. Inc./Newlink Genetics Corp. VSV-EBOV vaccine in Guinea.